Selected 2005 Public Offerings and Rule 144A Placements

Selected 2005 Public Offerings and Rule 144A Placements

Publication

 

  • Akamai Technologies — Public Offering of Common Stock — $204,000,000 — Counsel to Issuer
  • American Superconductor — Public Offering of Common Stock — $48,300,000 — Counsel to Issuer
  • AtheroGenics — Rule 144A Placement of 1.50% Convertible Notes Due 2012 — $200,000,000 — Counsel to Issuer
  • Barrier Therapeutics — Public Offering of Common Stock — $84,318,000 — Counsel to Underwriters
  • BE Semiconductor — Public Offering of 5.5% Convertible Notes Due 2012 — €46,000,000 — Counsel to Issuer
  • Besi — Public offering of 5.57% Convertible Notes due 2012 — Counsel to Issuer — €46,000,000
  • Bookham — Public Offering of Common Stock — $53,437,500 — Counsel to Issuer
  • Bottomline Technologies — Public Offering of Common Stock — $70,840,000 — Counsel to Issuer
  • CapitalSource — Public Offering of Common Stock — $429,275,000 — Counsel to Underwriters
  • CB Richard Ellis Group — Public Offering of Common Stock — $319,200,000 — Counsel to Selling Stockholder
  • CIT Group — Public Offerings of Medium-Term Notes — $11,032,000,000 — Counsel to Underwriters and Agents
  • Collagenex Pharmaceuticals — Public Offering of Common Stock — Counsel to Issuer — $29,000,000
  • Corporación Andina de Fomento — Public Offering of Floating Rate Notes — $250,000,000 — Counsel to Underwriters
  • Cynosure — Initial Public Offering of Common Stock — $86,250,000 — Counsel to Issuer
  • Dean Foods — Spinoff of TreeHouse Foods — $600,000,000 (spin-off valuation) — Counsel to Dean Foods
  • First Marblehead — Public Offering of Common Stock — $225,789,000 — Counsel to Issuer
  • Gas Turbine Efficiency — Initial Public Offering of Ordinary Shares — £5,400,000 — Counsel to Issuer
  • GTx — Public Offering of Common Stock — $49,335,000 — Counsel to Underwriters
  • Icagen — Initial Public Offering of Common Stock — $40,000,000 — Counsel to Issuer
  • Idenix Pharmaceuticals — Public Offering of Common Stock — $192,722,000 — Counsel to Issuer
  • iRobot — Initial Public Offering of Common Stock — $118,680,000 — Counsel to Underwriters
  • LIN Television — Rule 144A Placements of Senior Subordinated Notes — $365,000,000 — Counsel to Issuer
  • Momenta Pharmaceuticals — Public Offering of Common Stock — $130,434,000 — Counsel to Issuer
  • NxStage Medical — Initial Public Offering of Common Stock — $63,250,000 — Counsel to Issuer
  • Open Solutions — Rule 144A Placement of Senior Subordinated Convertible Notes due 2035 — $270,000,000 — Counsel to Issuer
  • Pioneer Investments — Closed-End Mutual Fund Public Offering of Preferred Stock — $234,500,000 — Counsel to Issuer
  • Progenics Pharmaceuticals — Public Offerings of Common Stock — $126,322,500 — Counsel to Underwriters
  • PS Business Parks — Public Offering of Preferred Stock — $82,500,000 — Counsel to Underwriters
  • Speedel Holding — Initial Public Offering on SWX Exchange — Counsel to Issuer
  • SPI Lasers — Initial Public Offering of Ordinary Shares — £12,000,000 — Counsel to Issuer
  • SSA Global Technologies — Initial Public Offering of Common Stock — $113,850,000 — Counsel to Underwriters
  • Thermo Electron — Rule 144A Placement of 5% Senior Notes due 2015 — $250,000,000 — Counsel to Issuer
  • Unica — Initial Public Offering of Common Stock — $55,200,000 — Counsel to Issuer
  • VistaPrint — Initial Public Offering of Common Stock — $138,220,000 — Counsel to Issuer
  • Website Pros — Initial Public Offering of Common Stock — $68,000,000 — Counsel to Underwriters
  • Witness Systems — Public Offering of Common Stock — $89,113,500 — Counsel to Underwriters

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.